Could microplastics sabotage cancer treatment? new study investigates
NCT ID NCT07690631
First seen Jul 08, 2026 · Last updated Jul 16, 2026 · Updated 3 times
Summary
This study looks at whether tiny plastic particles released from medical masks during radiation therapy could affect treatment for head and neck cancer. Researchers will measure microplastic exposure and track patient outcomes to see if there is any link. The goal is to improve safety and understand how environmental factors might influence cancer care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If microplastics are found to interfere with treatment, this could lead to safer radiotherapy practices and new guidelines to protect patients.
- What could go wrong
- This is an early observational study, so it may not prove cause and effect. The findings might not change current treatment or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with head and neck malignancies undergoing radiation therapy
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Any stage head and neck cancer patients * Eastern Cooperative Oncology Group performance status 0-2 * Undergoing radiotherapy with/without cisplatin chemopotentiation * Signed informed consent Exclusion Criteria: * Pregnancy or lactation * Mental illness * Prior or concurrent malignancies * Immunotherapy or immunosuppressive therapy * Immune diseases
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental pill HG146 put to the test against rare head and neck cancer
- Can a dental assistant keep cancer Patients' mouths healthier during radiation?
- Why do Non-Smokers get head and neck cancer? scientists probe tumor DNA
- Re-irradiation plus cetuximab targets head and neck tumors that return
- Sharper tumor maps: PET scans could tighten radiation beams
- Five days of radiation instead of weeks: a new test for head and neck cancer